Allogeneic peripheral blood progenitor cell transplantation in a murine model: Evidence for an improved graft-versus-leukemia effect

Blood

Volumn 90, Issue 4, 1997, Pages 1694-1700

  Glass, Bertram ^a   Uharek, Lutz ^a   Zeis, Matthias ^a   Dreger, Peter ^a   Löffler, Helmut ^a   Steinmann, Jörg ^a   Schmitz, Norbert ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CANCER RECURRENCE; CELL TRANSPLANTATION; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; LEUKEMIA CELL LINE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; WHOLE BODY RADIATION;

EID: 0030769382     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.4.1694.1694_1694_1700     Document Type: Article

References (39)

1. Barnes DWH, Loutit JF: Treatment of murine leukaemia with X-rays and homologous bone marrow: II. Br J Haematol 3:241, 1957
2. Bortin MM, Truitt RL, Rimm AA, Bach FH: Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity. Nature 281:490, 1979
3. Truitt RL, Atasoylu AA: Contribution of CD4+ and CDS+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow. Bone Marrow Transplant 8:51, 1991
4. Weiss L, Weigensberg M, Morecki S, Bar S, Cobbold S, Waldmann H, Slavin S: Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia. Cancer Immunol Immunother 31:236, 1990
5. Aizawa S, Sado T: Graft-versus-leukemia effect in MHC-compatible and -incompatible allogeneic bone marrow transplantation of radiation-induced, leukemia-bearing mice. Transplantation 52:885, 1991
6. Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD, Storb R: Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 300:1068, 1979
7. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555, 1990
8. Barrett AJ, Malkovska V: Graft-versus-leukemia: Understanding and using the alloimmune response to treat haematological malignancies. Br J Haematol 93:754, 1996
9. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Loeffler H, Hunter A, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666, 1995
10. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
11. Koerbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson BS, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation tor refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659, 1995
12. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 86:2842, 1995
13. Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Löffler H, Löffler M, Schmitz N: G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft. Br J Haematol 87:609, 1994
14. Bensinger WI, Clift R, Martin P, Appelbaum F, Demirer T, Gooley TA, Lilleby K, Rowley S, Sanders J. Storb R, Buckner CD: Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation. Blood 88:2794, 1996
15. Schmitz N, Bacigalupo A, Labopin M, Majolino I, Laporte JP, Brinch L, Cook G, Lambertenghi-Deliliers G, Lange A, Rozman C, Garcia-Conde J, Finke J, Domingo-Albos A, Gratwohl A on behalf of the EBMT: Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. Br J Haematol 95:715, 1996
16. Uharek L, Glass B, Gaska T, Gassmann W, Loeffler H, Mueller Ruchholtz W: Influence of donor lymphocytes on the incidence of primary graft failure after allogeneic bone marrow transplantation in a murine model. Br J Haematol 88:79, 1994
17. Glass B, Uharek L, Gassmann W, Focks B, Bolouri H, Loeffler H, Mueller-Ruchholtz W: Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease. Ann Hematol 64:255, 1992
18. Kim KJ, Kannellopoulus-Langevin C, Mervin RM, Sachs DH, Asofsky R: Establishment and characterization of Balb/c lymphoma lines with B cell properties. J Immunol 122:549, 1979
19. Martin PJ: Animal experimentation relevant to human marrow transplantation. Curr Opin Oncol 4:239, 1992
20. van Bekkum DW: What is graft versus host disease? Bone Marrow Transplant 7:110, 1991 (suppl 2)
21. Molineux G, Pojda Z, Hampson IN, Lord BI, Dexter TM: Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 76:2153, 1990
22. Van XQ, Hartley C, McElroy P, Chang A, McCrea C, McNiece I: Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long-term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice. Blood 85:2303, 1995
23. Andrews RG, Briddell RA, Knitter GH, Rowley SD, Appelbaum FR. McNiece IK: Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates. Blood 85:15, 1995
24. Sandmaier BM, Storb R, Santos EB, Krizanac Bengez L, Lian T, McSweeney PA, Yu C, Schuening FG, Deeg HJ, Graham T: Allogeneic transplant of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors. Blood 87:3508, 1996
25. Uharek L, Gassmann W, Glass B, Steinmann J, Loeffler H, Mueller-Ruchholtz W: Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation. Blood 79:1612, 1992
26. Bachar Lustig E, Rachamim N, Li HW, Lan F, Reisner Y: Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1:1268, 1995
27. Vallera DA, Soderling CC, Carlson GJ, Kersey JH: Bone marrow transplantation across major histocompatibility barriers in mice. Effect of elimination of T cells from donor grafts by treatment with monoclonal Thy-1.2 plus complement or antibody alone. Transplantation 31:218, 1981
28. Blazar BR, Roopenian DC, Taylor PA. Christianson GJ, Panoskaltsis Mortari A, Vallera DA: Lack of GVHD across classical, single minor histocompatibility (miH) locus barriers in mice. Transplantation 61:619, 1996
29. Ferrara JL, Deeg HJ: Graft-versus-host disease. N Engl J Med 324:667, 1991
30. Storb R, Thomas ED: Graft-versus-host disease in dog and man: The Seattle experience. Immunol Rev 88:215, 1985
31. Pan L, Delmonte J, Jalonen CK, Ferrara JLM: Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 86:4422, 1995
32. Krenger W, Snyder KM, Byon JCH, Falzarano G, Ferrara JLM: Polarized type 2 alloreactive CD4+ and CDS+ donor cells fail to induce experimental acute graft-versus-host disease. J Immunol 155:585, 1995
33. Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman E, Hoffmann RG, Jacobsen SJ, Marmont AM, McGlave PB, Messner HA, Rimm AA, Rozman C, Speck B, Tura S, Weiner RS, Bortin MM: Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med 108:806, 1988
34. Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW, Champlin RE, Dicke KA, Goldman JM, Good RA, Herzig RH, Hong R, Masaoka T, Rimm AA, Ringdén O, Speck B, Weiner RS, Bonin MM: T-cell depletion of HLA-identical transplants in leukemia. Blood 78:2120, 1991
35. Weiss L, Weigcnsberg M, Morecki S, Bar S, Cobhold S, Waldmann H, Slavin S: Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia. Cancer Immunol Immunother 31:236, 1990
36. O'Kunewick JP, Kociban DL, Machen LL, Buffo MJ: Comparison of the effects of CD3 and CD5 donor T cell depletion on graft-versus-leukemia in a murine model for MHC-matched unrelated-donor transplantation. Bone Marrow Transplant 13:11, 1994
37. Hauch M, Gazzola MV, Small T, Bordignon C, Barnett L, Cunningham I, Castro Malaspinia H, O'Reilly RJ, Keever CA: Antileukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia. Blood 75:2250, 1990
38. Zeis M, Uharek L, Glass B, Gaska T, Steinmann J, Gassmann W, Loeffler H, Mueller-Ruchholtz W: Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice. Transplantation 59:1734, 1995
39. Glass B, Uharek L, Zeis M, Loeffler H, Mueller-Ruchholtz W, Gassmann W: Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells. Br J Haematol 93:412, 1996